Dent Neurologic Institute, 3980 Sheridan Drive, Suite 600, Amherst, NY, 14226, USA.
Dent Neurologic Institute, 3980 Sheridan Drive, Suite 300, Amherst, NY, 14226, USA.
Curr Pain Headache Rep. 2021 Feb 25;25(3):16. doi: 10.1007/s11916-020-00931-2.
The use of cannabis for the treatment of migraine has become an area of interest with the legalization of medical cannabis in the USA. Understanding the mechanisms of cannabinoids, available studies, and best clinical recommendations is crucial for headache providers to best serve patients.
Patients utilizing medical cannabis for migraine have reported improvement in migraine profile and common comorbidities. Reduction in prescription medication is also common, especially opioids. Side effects exist, with the majority being mild. Not enough data is available for specific dose recommendations, but THC and CBD appear to mediate these observed effects. The purpose of this article is twofold: review the limited research surrounding cannabis for migraine disease and reflect on clinical management experiences to provide recommendations that best capture the potential use of cannabis for migraine.
综述目的:随着美国医用大麻合法化,大麻在偏头痛治疗中的应用已成为一个热点领域。了解大麻素的作用机制、现有研究和最佳临床推荐对于头痛治疗医生为患者提供最佳服务至关重要。
最近的发现:使用医用大麻治疗偏头痛的患者报告称偏头痛症状和常见合并症得到改善。处方药物的使用减少也很常见,尤其是阿片类药物。存在副作用,大多数是轻微的。目前尚无特定剂量推荐的足够数据,但 THC 和 CBD 似乎介导了这些观察到的效果。本文的目的有两个:回顾大麻治疗偏头痛疾病的有限研究,并反思临床管理经验,以提供最佳利用大麻治疗偏头痛的建议。